Epstein-Barr Virus Positive
2 clinical trials · Condition
◉ Watch Epstein-Barr Virus Positive
| Record | Firm | Date |
|---|---|---|
| Durvalumab and Epacadostat for Treatment of Unresectable, Recurrent, or Metastatic Epstein-Barr Virus Positive Nasopharyngeal Cancer (NCT04231864) | Alain Algazi | 2020-12-01 |
| Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer (NCT03257163) | Rutgers, The State University of New Jersey | 2017-09-29 |
Track Epstein-Barr Virus Positive automatically
Every clearance here is in the API, with alerts when new ones post.